Publications by authors named "Julian Carretero"

43Publications

Locus Overexpression Reduces Body Weight, Total Cholesterol and Glucose Levels in Mice Fed with Two Different Diets.

Nutrients 2020 Oct 14;12(10). Epub 2020 Oct 14.

Genomics and Diabetes Unit, Health Research Institute Clinic Hospital of Valencia-INCLIVA, Menendez Pelayo 4acc, 46010 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/nu12103130DOI Listing
October 2020

LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics.

Anal Chem 2019 01 13;91(1):836-845. Epub 2018 Dec 13.

Biomarkers and Precision Medicine Unit and Analytical Unit , Instituto de Investigación Sanitaria Fundación Hospital La Fe , Valencia 46026 , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.analchem.8b03409DOI Listing
January 2019

Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.

Cancer Discov 2016 09 16;6(9):1006-21. Epub 2016 Jun 16.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-16-0164DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010480PMC
September 2016

Expression inactivation of SMARCA4 by microRNAs in lung tumors.

Hum Mol Genet 2015 Mar 29;24(5):1400-9. Epub 2014 Oct 29.

Department of Biochemistry and Molecular Biology, University of Granada, Granada, Spain, Centre for Genomics and Oncological Research (GENYO), Granada, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddu554DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321447PMC
March 2015

β-catenin contributes to lung tumor development induced by EGFR mutations.

Cancer Res 2014 Oct 27;74(20):5891-902. Epub 2014 Aug 27.

Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Harvard Stem Cell Institute, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0184DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199914PMC
October 2014

Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.

PLoS One 2013 15;8(11):e80885. Epub 2013 Nov 15.

State Key Laboratory of Proteomics, Genetic Laboratory of Development and Diseases, Institute of Biotechnology, Beijing, China ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America ; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0080885PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829911PMC
June 2014

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.

Cancer Discov 2013 Dec 27;3(12):1355-63. Epub 2013 Sep 27.

Departments of 1Medicine and 2Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute; 3Harvard Medical School; 4Ludwig Institute for Cancer Research; 5Department of Neurosurgery, Massachusetts General Hospital; 6Belfer Institute for Applied Cancer Science; 7Department of Pathology, Brigham and Women's Hospital, Boston; 8Broad Institute, Cambridge, Massachusetts; 9UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and 10Department of Molecular Pharmacology and Therapeutics, Oncology Institute, Loyola University, Chicago, Illinois; 11Department of Physiology, University of Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864135PMC
December 2013

Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.

Clin Cancer Res 2013 Nov 17;19(22):6183-92. Epub 2013 Sep 17.

Authors' Affiliations: Department of Molecular Pharmacology and Therapeutics, Oncology Research Institute, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois; Departments of Medical Oncology and Radiation Oncology; Belfer Institute for Applied Cancer Science; Ludwig Center at Dana-Farber/Harvard Cancer Center; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; Department of Medicine, Brigham and Women's Hospital; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Departament de Fisiologia, Facultat de Farmàcia, Universitat de València, Valencia, Spain; and Department of Pediatrics, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838895PMC
November 2013

Novel transcriptional targets of the SRY-HMG box transcription factor SOX4 link its expression to the development of small cell lung cancer.

Cancer Res 2012 Jan 14;72(1):176-86. Epub 2011 Nov 14.

Genes and Cancer Group, Cancer Epigenetics and Biology Program, PEBC, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-3506DOI Listing
January 2012

Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism.

Mol Cancer Ther 2008 Oct;7(10):3330-42

Department of Physiology, Faculty of Medicine and Odontology, University of Valencia, 17 Av. Blasco Ibañez, 46010 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-08-0363DOI Listing
October 2008

Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels.

Nitric Oxide 2008 Sep 23;19(2):107-14. Epub 2008 Apr 23.

Department of Physiology, University of Valencia, 17 Av. Blasco Ibanez, Valencia 46010, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.niox.2008.04.010DOI Listing
September 2008

Mild ocular myopathy associated with a novel mutation in mitochondrial twinkle helicase.

Neuromuscul Disord 2007 Oct 5;17(9-10):677-80. Epub 2007 Jul 5.

Centro de Investigación, Hospital Universitario 12 de Octubre, Av. de Córdoba s/n, 28041 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nmd.2007.05.006DOI Listing
October 2007

Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.

Clin Cancer Res 2007 May;13(9):2658-66

Department of Physiology, Faculty of Medicine and Odontology, University of Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2642DOI Listing
May 2007

Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.

Hum Mol Genet 2005 Apr 24;14(7):973-82. Epub 2005 Feb 24.

Lung Cancer Group, Molecular Pathology Programme, Spanish National Cancer Centre, C/Melchior Fernandez Almagro 3, 28029 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddi091DOI Listing
April 2005

Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.

Genes Chromosomes Cancer 2004 Oct;41(2):170-7

Lymphoma and Lung Cancer Group, Molecular Pathology Program. Spanish National Cancer Centre (CNIO), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20068DOI Listing
October 2004

Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.

Oncogene 2004 May;23(22):4037-40

Lymphoma and Lung Cancer Group, Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, Calle Melchor Fernández Almagro, 3, 28029 Madrid, Spain.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1207502
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1207502DOI Listing
May 2004

Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium.

J Biol Chem 2003 Oct 24;278(41):39591-9. Epub 2003 Jul 24.

Department of Physiology, University of Valencia, Av. Blasco Ibañez 17, Valencia 46010, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M303753200DOI Listing
October 2003

Inhibition of cancer growth by resveratrol is related to its low bioavailability.

Free Radic Biol Med 2002 Aug;33(3):387-98

Departamento de Fisiología, Universidad de Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0891-5849(02)00911-5DOI Listing
August 2002